SEC. 5. COMPREHENSIVE PLAN. 
Not later than 180 days after the date of enactment 
of this Act, the Administrator of the Drug Enforcement 
Administration shall establish and implement an operation 
and response plan to address counterfeit fentanyl or meth-
amphetamine substances that includes— 
(1) strategies to enable and empower Federal 
law enforcement efforts to investigate and seize 
counterfeit fentanyl or methamphetamine sub-
stances; 
(2) specific ways that education and prevention 
efforts to stop the use of counterfeit fentanyl or 
methamphetamine substances will be increased, in-
cluding how— 
(A) ongoing efforts, such as Operation En-
gage, are effective in increasing education and 
prevention; and 
(B) how the efforts described in subpara-
graph (A) are tailored to youth and teen access; 
and 
(3) an audit of current campaigns, including 
the ‘‘One Pill Can Kill’’ campaign, on counterfeit 
fentanyl or methamphetamine substances, including 
a review of data and other available information on 
how such campaigns can be tailored, adjusted, or 
VerDate Sep 11 2014 
17:56 Aug 12, 2022
Jkt 029200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H8175.IH
H8175
pamtmann on DSKBC07HB2PROD with BILLS
improved to better address the flow of counterfeit 
fentanyl or methamphetamine substances. 
SEC. 6. REPORT TO CONGRESS. 
(a) REPORT.—Not later than 1 year after the date 
of enactment of this Act, and every year thereafter, the 
Attorney General, in consultation with the Administrator 
of the Drug Enforcement Administration and Director of 
the Office of National Drug Control Policy, shall submit 
to Congress a report on information regarding the collec-
tion and prosecutions of counterfeit fentanyl or meth-
amphetamine substances. 
(b) CONTENTS.—The report required under sub-
section (a) shall include the following: 
(1) Data on the aggregate number of counter-
feit fentanyl or methamphetamine substances seized 
and collected by Federal law enforcement agencies. 
(2) A breakdown on how many counterfeit 
fentanyl or methamphetamine substances are in pill 
form. 
(3) A breakdown on which illicit substances are 
present in the counterfeit fentanyl or methamphet-
amine substances that are in pill form. 
(4) Data outlining where and when counterfeit 
fentanyl or methamphetamine substances were 
seized. 
VerDate Sep 11 2014 
17:56 Aug 12, 2022
Jkt 029200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H8175.IH
H8175
pamtmann on DSKBC07HB2PROD with BILLS
(5) Data on the charges filed against those 
manufacturing, distributing, or dispensing, or pos-
sessing with the intent to distribute or dispense a 
counterfeit fentanyl or methamphetamine substance, 
particularly in pill form, pursuant to paragraph (1) 
or (2) of section 401(a) of the Controlled Substances 
Act (21 U.S.C. 841(a)), unless disclosure of such 
data would require unsealing an indictment or would 
undermine investigations and charges brought by the 
Department of Justice. 
(6) Data on the convictions and sentences 
against those who are found guilty under paragraph 
(1) or (2) of section 401(a) of the Controlled Sub-
stances Act (21 U.S.C. 841(a)) as it pertains to 
counterfeit fentanyl or methamphetamine sub-
stances, particularly those in pill form. 
(7) Any prevention measures that the Depart-
ment of Justice, Drug Enforcement Administration, 
or Office of National Drug Control Policy are under-
taking to limit and reduce the spread of counterfeit 
fentanyl or methamphetamine substances in pill 
form, including ongoing public awareness campaigns. 
Æ 
VerDate Sep 11 2014 
17:56 Aug 12, 2022
Jkt 029200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6301
E:\BILLS\H8175.IH
H8175
pamtmann on DSKBC07HB2PROD with BILLS